Turnover of pharmaceuticals in Norway 2018, by ATC main groups
The pharmaceuticals belonging to ATC main group L, Antineoplastic and immunomodulating agents, generated the highest turnover in Norway in 2018, with a value of around 6.8 billion Norwegian kroner. The ATC main group with the second highest turnover was group N, which is drugs used for nervous system. The turnover from pharmaceuticals in this ATC main group was around 4.2 billion Norwegian kroner.
